Comparative Study of GlySure Continuous Intra-vascular Glucose Monitoring and Intermittent Monitoring in Medical ICU

Exclusion Criteria

• •1. Patient or legal representative is unable to provide written informed consent
• •2. Patient who is pregnant
• •3. Patient who is currently being administered Mannitol and/or may require the administration of Mannitol whilst in the ICU
• •4. Patient with history of pulmonary embolism (PE)
• •5. Patient with history of thrombosis
• •6. Patient with known hyper-coagulation
• •7. Patient with known history of heparin hypersensitivity
• •8. Patient with history of heparin induced thrombocytopenia
• •9. Participation in a clinical study involving an unlicensed pharmaceutical product or device within the 3 months prior to enrolment in this study
• •10. Patient with known hypersensitivity/allergy to adhesive I.V. dressings such as 3M Tegaderm film or StatLock® devices